Wellington Management Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.5B | Sell |
6,897,816
-8,028,867
| -54% | -$1.78B | 0.28% | 82 |
|
|
2025
Q4 | $3.41B | Buy |
14,926,683
+4,389,782
| +42% | +$1,000M | 0.6% | 22 |
|
|
2025
Q3 | $2.44B | Buy |
10,536,901
+8,646,424
| +457% | +$1.76B | 0.43% | 49 |
|
|
2025
Q2 | $351M | Buy |
1,890,477
+78,100
| +4% | +$14.5M | 0.06% | 247 |
|
|
2025
Q1 | $380M | Sell |
1,812,377
-424,271
| -19% | -$82.5M | 0.07% | 222 |
|
|
2024
Q4 | $397M | Buy |
2,236,648
+669,493
| +43% | +$123M | 0.07% | 223 |
|
|
2024
Q3 | $309M | Sell |
1,567,155
-1,315,426
| -46% | -$246M | 0.05% | 299 |
|
|
2024
Q2 | $494M | Buy |
2,882,581
+37,498
| +1% | +$6.21M | 0.09% | 211 |
|
|
2024
Q1 | $518M | Buy |
2,845,083
+1,890,709
| +198% | +$326M | 0.09% | 215 |
|
|
2023
Q4 | $148M | Buy |
954,374
+536,730
| +129% | +$78.3M | 0.03% | 462 |
|
|
2023
Q3 | $62.3M | Buy |
417,644
+88,172
| +27% | +$12.9M | 0.01% | 643 |
|
|
2023
Q2 | $44.4M | Sell |
329,472
-520
| -0.2% | -$76.3K | 0.01% | 734 |
|
|
2023
Q1 | $52.6M | Buy |
329,992
+39,559
| +14% | +$6.05M | 0.01% | 681 |
|
|
2022
Q4 | $46.9M | Sell |
290,433
-21,814
| -7% | -$3.34M | 0.01% | 699 |
|
|
2022
Q3 | $41.9M | Sell |
312,247
-16,790
| -5% | -$2.41M | 0.01% | 712 |
|
|
2022
Q2 | $50.4M | Buy |
329,037
+55,853
| +20% | +$8.53M | 0.01% | 675 |
|
|
2022
Q1 | $44.3M | Sell |
273,184
-7,052
| -3% | -$1.02M | 0.01% | 791 |
|
|
2021
Q4 | $37.9M | Buy |
280,236
+18,416
| +7% | +$2.18M | 0.01% | 914 |
|
|
2021
Q3 | $28.2M | Sell |
261,820
-21,431
| -8% | -$2.45M | ﹤0.01% | 987 |
|
|
2021
Q2 | $31.9M | Buy |
283,251
+79,592
| +39% | +$8.96M | 0.01% | 974 |
|
|
2021
Q1 | $22M | Sell |
203,659
-26,017
| -11% | -$2.78M | ﹤0.01% | 1047 |
|
|
2020
Q4 | $24.6M | Sell |
229,676
-45,230
| -16% | -$4.35M | ﹤0.01% | 988 |
|
|
2020
Q3 | $24.1M | Buy |
274,906
+66,904
| +32% | +$6.3M | 0.01% | 903 |
|
|
2020
Q2 | $20.4M | Sell |
208,002
-27,220
| -12% | -$2.4M | ﹤0.01% | 920 |
|
|
2020
Q1 | $17.9M | Buy |
235,222
+583
| +0.2% | +$49.7K | ﹤0.01% | 903 |
|
|
2019
Q4 | $20.8M | Buy |
234,639
+39,896
| +20% | +$3.31M | ﹤0.01% | 974 |
|
|
2019
Q3 | $14.7M | Sell |
194,743
-29,260
| -13% | -$2.01M | ﹤0.01% | 1052 |
|
|
2019
Q2 | $16.3M | Buy |
224,003
+186,339
| +495% | +$14.6M | ﹤0.01% | 1065 |
|
|
2019
Q1 | $3.04M | Sell |
37,664
-3,839
| -9% | -$314K | ﹤0.01% | 1506 |
|
|
2018
Q4 | $3.83M | Sell |
41,503
-3,407
| -8% | -$300K | ﹤0.01% | 1455 |
|
|
2018
Q3 | $4.25M | Sell |
44,910
-5,270
| -11% | -$500K | ﹤0.01% | 1521 |
|
|
2018
Q2 | $4.65M | Buy |
50,180
+3,364
| +7% | +$329K | ﹤0.01% | 1511 |
|
|
2018
Q1 | $4.43M | Sell |
46,816
-5,503
| -11% | -$605K | ﹤0.01% | 1521 |
|
|
2017
Q4 | $5.06M | Buy |
52,319
+6,627
| +15% | +$625K | ﹤0.01% | 1476 |
|
|
2017
Q3 | $4.06M | Buy |
45,692
+21,254
| +87% | +$1.62M | ﹤0.01% | 1534 |
|
|
2017
Q2 | $1.77M | Buy |
24,438
+85
| +0.3% | +$5.71K | ﹤0.01% | 1728 |
|
|
2017
Q1 | $1.59M | Sell |
24,353
-3,930
| -14% | -$247K | ﹤0.01% | 1795 |
|
|
2016
Q4 | $1.77M | Sell |
28,283
-5,659
| -17% | -$345K | ﹤0.01% | 1720 |
|
|
2016
Q3 | $2.14M | Buy |
+33,942
| New | +$2.2M | ﹤0.01% | 1628 |
|
|
2015
Q3 | – | Sell |
-43,786
| Closed | -$2.94M | – | 2168 |
|
|
2015
Q2 | $2.94M | Buy |
43,786
+14
| +0% | +$914 | ﹤0.01% | 1563 |
|
|
2015
Q1 | $2.56M | Sell |
43,772
-863
| -2% | -$52.1K | ﹤0.01% | 1626 |
|
|
2014
Q4 | $2.92M | Buy |
44,635
+16,205
| +57% | +$1.02M | ﹤0.01% | 1589 |
|
|
2014
Q3 | $1.64M | Sell |
28,430
-28,101
| -50% | -$1.56M | ﹤0.01% | 1712 |
|
|
2014
Q2 | $3.19M | Sell |
56,531
-2,692
| -5% | -$141K | ﹤0.01% | 1570 |
|
|
2014
Q1 | $3.04M | Sell |
59,223
-1,726,907
| -97% | -$87.3M | ﹤0.01% | 1593 |
|
|
2013
Q4 | $94.3M | Sell |
1,786,130
-6,717,543
| -79% | -$330M | 0.03% | 546 |
|
|
2013
Q3 | $380M | Sell |
8,503,673
-138
| -0% | -$6.12K | 0.12% | 195 |
|
|
2013
Q2 | $352M | Buy |
+8,503,811
| New | +$372M | 0.11% | 191 |
|
Other funds holding ABBV
VCM
VPM
Wellington Management Group's ABBV Position: Q1 2026 in Review
Wellington Management Group reduced its AbbVie (ABBV) stake by 54% in Q1 2026, selling an estimated $1.78B and leaving 6,897,816 shares worth $1.5B. The position accounts for 0.28% of the portfolio, ranked #82.
Wellington Management Group first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $3.41B in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Wellington Management Group held 6,897,816 shares of AbbVie worth $1.5B as of Q1 2026.
- Wellington Management Group sold 8,028,867 AbbVie shares in Q1 2026, an estimated $1.78B.
- AbbVie made up 0.28% of Wellington Management Group's portfolio in Q1 2026, its #82 holding.
- Wellington Management Group first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
- Wellington Management Group's AbbVie position peaked at $3.41B in Q4 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.